X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
oncology (6) 6
animals (5) 5
female (4) 4
humans (4) 4
mice (4) 4
acquired resistance (3) 3
alk (3) 3
article (3) 3
crizotinib (3) 3
mice, knockout (3) 3
nuclear receptors (3) 3
open-label (3) 3
acquired-resistance (2) 2
adult (2) 2
atherosclerosis (2) 2
cancer (2) 2
dendritic cells (2) 2
disease (2) 2
essential thrombocytosis (2) 2
hematopoietic stem-cell transplantation (2) 2
immunology (2) 2
immunotherapy (2) 2
interferon (2) 2
intestines - immunology (2) 2
jak2 v617f (2) 2
lorlatinib (2) 2
lymph-nodes (2) 2
macrophage (2) 2
mice, inbred c57bl (2) 2
monocyte (2) 2
myelofibrosis (2) 2
myeloproliferative neoplasms (2) 2
nuclear receptor subfamily 4, group a, member 1 - genetics (2) 2
pembrolizumab (2) 2
polycythemia vera (2) 2
radiation (2) 2
radiotherapy (2) 2
research (2) 2
ros1 (2) 2
surgery (2) 2
tet2 (2) 2
toll-like receptors (2) 2
adaptation, psychological (1) 1
adaptive immunity (1) 1
african-american (1) 1
age groups (1) 1
aged (1) 1
aged, 80 and over (1) 1
alectinib (1) 1
anaplastic lymphoma kinase (1) 1
anaplastic lymphoma kinase - genetics (1) 1
and nsclc (1) 1
antigens, ly - immunology (1) 1
antimicrobial cationic peptides - metabolism (1) 1
aortic-wall (1) 1
apolipoproteins e - deficiency (1) 1
apolipoproteins e - genetics (1) 1
apolipoproteins e - physiology (1) 1
apoptosis - immunology (1) 1
atezolizumab (1) 1
atherosclerosis - etiology (1) 1
atherosclerosis - pathology (1) 1
atherosclerosis - physiopathology (1) 1
biology (1) 1
biology and life sciences (1) 1
blockade (1) 1
blood monocyte subsets (1) 1
body image (1) 1
body-image (1) 1
bone marrow - immunology (1) 1
bone-marrow (1) 1
brain metastases (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - radiotherapy (1) 1
brain neoplasms - secondary (1) 1
brain neoplasms - therapy (1) 1
breast (1) 1
breast cancer (1) 1
breast neoplasms - psychology (1) 1
brigatinib (1) 1
cancer detection and diagnosis (1) 1
cancer patients (1) 1
cancer survivors (1) 1
cancer survivors - psychology (1) 1
cancer therapies (1) 1
cardiac & cardiovascular systems (1) 1
care and treatment (1) 1
cd4-positive t-lymphocytes - immunology (1) 1
cell biology (1) 1
cell cycle - immunology (1) 1
cell death (1) 1
cell differentiation - immunology (1) 1
cell line, tumor (1) 1
cell lung-cancer (1) 1
ceritinib (1) 1
chemical and pharmacologic phenomena (1) 1
chemotherapy (1) 1
children (1) 1
clonal deletion (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Reports, ISSN 2211-1247, 12/2014, Volume 9, Issue 5, pp. 1567 - 1573
Journal Article
Circulation Research, ISSN 0009-7330, 02/2012, Volume 110, Issue 3, pp. 416 - 427
Journal Article
Cancer Discovery, ISSN 2159-8274, 06/2018, Volume 8, Issue 6, pp. 714 - 729
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 04/2018, Volume 13, Issue 4, pp. 550 - 558
Intracranial metastases are a common cause of morbidity and mortality in patients with advanced NSCLC, and are frequently managed with radiation therapy (RT).... 
Brain metastases | PD-1 inhibitor | NSCLC | Immunotherapy | Radiation | CTLA-4 BLOCKADE | PEMBROLIZUMAB | NECROSIS | MELANOMA BRAIN METASTASES | STEREOTACTIC RADIOSURGERY | ONCOLOGY | RESPIRATORY SYSTEM | DISEASE | RADIOTHERAPY | IPILIMUMAB
Journal Article
Mucosal Immunology, ISSN 1933-0219, 2014, Volume 7, Issue 5, pp. 1045 - 1057
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 11/2019, Volume 25, Issue 22, pp. 6662 - 6670
Purpose: Acquired resistance to next-generation ALK tyrosine kinase inhibitors (TKIs) is often driven by secondary ALK mutations. Here, we investigated utility... 
CELL LUNG-CANCER | ONCOLOGY | ACQUIRED-RESISTANCE | CRIZOTINIB | VALIDATION | OPEN-LABEL | LORLATINIB
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 4723 - 4723
Abstract Abstract 4723 ‘Resident’ or ‘patrolling’ monocytes have recently been described as a unique subset of myeloid cells that differ in phenotype and... 
Journal Article
Circulation Research, ISSN 0009-7330, 02/2012, Volume 110, Issue 3, pp. 416 - 427
RATIONALE:: NR4A1 (Nur77) is a nuclear receptor that is expressed in macrophages and within atherosclerotic lesions, yet its function in atherosclerosis is... 
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 1361 - 1361
Abstract Abstract 1361 Poster Board I-385 The expression of Nur77/NR4A1, one member of the Nur Orphan Nuclear Receptor family, is tightly regulated in many... 
Journal Article
Nature Immunology, ISSN 1529-2908, 07/2011, Volume 12, Issue 8, pp. 778 - 785
The transcription factors that regulate differentiation into the monocyte subset in bone marrow have not yet been identified. Here we found that the orphan... 
Journal Article
Therapeutic Advances in Hematology, ISSN 2040-6207, 2012, Volume 3, Issue 3, pp. 131 - 146
Major advances in myeloproliferative neoplasms in the last decade have cast light on their complexity. The identification of JAK2 (V617F) briefly promised a... 
hematopoietic stem-cell transplantation | myeloproliferative neoplasms | myelofibrosis | JAK2 V617F | polycythemia vera | TET2 | essential thrombocytosis | interferon
Journal Article
Therapeutic Advances in Hematology, ISSN 2040-6207, 6/2012, Volume 3, Issue 3, pp. 131 - 146
Major advances in myeloproliferative neoplasms in the last decade have cast light on their complexity. The identification of JAK2V617F briefly promised a... 
hematopoietic stem-cell transplantation | myeloproliferative neoplasms | myelofibrosis | Reviews | JAK2 V617F | polycythemia vera | TET2 | essential thrombocytosis | interferon
Journal Article
JAMA Oncology, ISSN 2374-2437, 02/2018, Volume 4, Issue 2, pp. 253 - 255
This cohort study evaluates the clinical outcomes in patients with metastatic lung cancer treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy. 
PEMBROLIZUMAB | MELANOMA | ONCOLOGY | NIVOLUMAB | Online First | Research | Letters | Research Letter
Journal Article
JCO precision oncology, ISSN 2473-4284, 2017, Volume 2017
The ROS1 tyrosine kinase is activated through gene rearrangements in 1-2% of non-small cell lung cancer (NSCLC), conferring sensitivity to treatment with the... 
Journal Article
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.